Ryvu Therapeutics Future Growth
Future criteria checks 1/6
Ryvu Therapeutics's earnings are forecast to decline at 16.3% per annum while its annual revenue is expected to grow at 13.5% per year.
Key information
-16.3%
Earnings growth rate
n/a
EPS growth rate
Life Sciences earnings growth | 25.5% |
Revenue growth rate | 13.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 May 2024 |
Recent future growth updates
Recent updates
Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt
Oct 20We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate
Aug 02Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?
Jan 25What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?
Feb 05Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return
Dec 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 86 | -176 | -92 | -171 | 1 |
12/31/2025 | 132 | -140 | -100 | -148 | 2 |
12/31/2024 | 91 | -162 | -162 | -151 | 1 |
3/31/2024 | 74 | -94 | -103 | -95 | N/A |
12/31/2023 | 67 | -92 | -93 | -85 | N/A |
9/30/2023 | 84 | -73 | -6 | 0 | N/A |
6/30/2023 | 88 | -66 | -2 | 3 | N/A |
3/31/2023 | 80 | -75 | 4 | 10 | N/A |
12/31/2022 | 68 | -84 | 15 | 21 | N/A |
9/30/2022 | 50 | -94 | -51 | -44 | N/A |
6/30/2022 | 37 | -105 | -68 | -58 | N/A |
3/31/2022 | 36 | -92 | -80 | -69 | N/A |
12/31/2021 | 35 | -79 | -71 | -59 | N/A |
9/30/2021 | 26 | -72 | -74 | -58 | N/A |
6/30/2021 | 25 | -61 | -61 | -37 | N/A |
3/31/2021 | 30 | -41 | -38 | -5 | N/A |
12/31/2020 | 37 | -32 | -45 | -11 | N/A |
9/30/2020 | 38 | -40 | -57 | -23 | N/A |
6/30/2020 | 41 | -32 | -74 | -51 | N/A |
3/31/2020 | 17 | -41 | -36 | -17 | N/A |
12/31/2019 | 34 | -44 | -41 | -17 | N/A |
9/30/2019 | 53 | -53 | -55 | -27 | N/A |
6/30/2019 | 19 | -60 | -38 | -6 | N/A |
3/31/2019 | 116 | -28 | -77 | -49 | N/A |
12/31/2018 | 52 | -23 | -44 | -26 | N/A |
9/30/2018 | 49 | 2 | -22 | -7 | N/A |
6/30/2018 | 96 | 14 | -19 | -4 | N/A |
3/31/2018 | 102 | 21 | 4 | 22 | N/A |
12/31/2017 | 105 | 6 | N/A | 11 | N/A |
9/30/2017 | 104 | 13 | N/A | 7 | N/A |
6/30/2017 | 97 | 14 | N/A | 8 | N/A |
3/31/2017 | 80 | 10 | N/A | -24 | N/A |
12/31/2016 | 66 | 3 | N/A | -6 | N/A |
9/30/2016 | 60 | 0 | N/A | -6 | N/A |
6/30/2016 | 60 | -1 | N/A | -10 | N/A |
3/31/2016 | 57 | 3 | N/A | -14 | N/A |
12/31/2015 | 56 | 6 | N/A | -16 | N/A |
9/30/2015 | 51 | 7 | N/A | -10 | N/A |
6/30/2015 | 48 | 7 | N/A | -8 | N/A |
3/31/2015 | 46 | 7 | N/A | -5 | N/A |
12/31/2014 | 41 | 6 | N/A | -5 | N/A |
9/30/2014 | 43 | 4 | N/A | -6 | N/A |
6/30/2014 | 35 | 2 | N/A | -5 | N/A |
3/31/2014 | 27 | -1 | N/A | -6 | N/A |
12/31/2013 | 22 | -2 | N/A | -7 | N/A |
9/30/2013 | 10 | -5 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RVU is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RVU is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RVU is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RVU's revenue (13.5% per year) is forecast to grow faster than the Polish market (4.4% per year).
High Growth Revenue: RVU's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RVU's Return on Equity is forecast to be high in 3 years time